Future of Medtech: Define New Markets Before They Define You
Medtech companies willing to do business in new ways and develop holistic approaches to meet their customers’ needs stand to exceed industry growth forecasts and reap significant revenue rewards. To achieve this growth, medtech companies must move beyond the traditional playbook of incremental product improvements, narrow M&A activity and investment in sales and marketing efforts. This report from PwC – an associate member of AdvaMed® – presents three growth strategies to win in this competitive and rapidly changing environment. Each medtech company’s path to growth can draw from any or all of these strategies. The most successful will find the right blend of the three.
Related Reading
News / Business Development / Diagnostics / Health Access
Scott Garrett Named 2026 Recipient of AdvaMedDx® Lifetime of Leadership & Service Award
October 19, 2026
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across diagnostics, life sciences, medical products, specialty distribution, and laboratory services.
News / Business Development / Diagnostics / Health Access
AdvaMed Names Vince Forlenza 2026 Lifetime Achievement Award Winner
October 16, 2026
WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement Award. Forlenza will receive the award during The MedTech Conference in Boston Oct. 18-21.
Blog / Business Development / Small Business / The MedTech Conference
AdvaMed® in Action: Where Emerging Medtech Leaders Go Next
September 22, 2026
JC Scott shares how AdvaMed Accel priorities—from raising capital to building a stronger path to commercialization—will come to life at #MTC26 in Boston.
News / Health Access / Regulatory Affairs / Small Business
Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures
September 18, 2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) — Emanate Biomedical, Inc., a medical technology company creating a new category of clinician-directed at-home oral care, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for Perio PODS™, a periodontal wound dressing consisting of single-use, patient-matched dental trays preloaded with engineered hydrogel.
News / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed Names Juan Carlos “JC” Scott Chief Strategy Officer and Executive Director of AdvaMed Accel
August 12, 2026
WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.
Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business
Medtech Showcase & Reception on Capitol Hill
September 16, 2026
5:00 PM – 7:00 PM
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.
News / Small Business
Francis Medical Announces Publication of VAPOR 2 Pivotal Trial Results in The Journal of Urology
July 2, 2026
MAPLE GROVE, Minn., June 30, 2026 — Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced the publication of the initial report from its VAPOR 2 pivotal clinical study in The Journal of Urology, one of the world’s leading peer-reviewed urology journals.
News / Medical Imaging / Small Business
Sonex Health Announces Data from Largest-ever U.S. Study Proving UltraGuideCTR™ Delivers Compelling Results for Carpal Tunnel Patients
June 15, 2026
EAGAN, Minn. – June 9, 2026 – Sonex Health, Inc. (Sonex Health) and The Institute of Advanced Ultrasound Guided Procedures today announced publication of six-month data demonstrating the safety and efficacy of ultrasound-guided carpal tunnel release (UGCTR) using UltraGuideCTR™. The study, published in the Journal of Hand Surgery Global Online, represents the largest prospective evaluation of UGCTR to date.